Scaling interactive apps for clinical and RWE impact
April 16th at 11 AM PT | 1 PM ET | 30 min session
Register now
Interactive applications are changing how clinical and real-world evidence (RWE) teams deliver insights, enabling stakeholders to explore results in real time rather than waiting for static reports. Yet adoption can be inconsistent without clear use cases, intuitive design, and the right governance.
Drawing on lessons from clinical trial reporting and RWE dashboards, this session shares best practices for making interactive apps effective and sustainable across organizations.
Attendees will learn how to:
- Decide when interactive apps add more value over static outputs
- Design apps that drive adoption across diverse clinical and RWE stakeholders
- Balance self-service interactivity with regulatory and compliance requirements
- Scale apps sustainably across organizations to ensure long-term impact
Rather than focusing on building apps alone, this session shows how to embed interactive applications as an organizational capability—ensuring adoption, compliance, and lasting impact.
Featured speakers
Agnes Youn
Solutions engineer
Agnes Youn is a Senior Sales Engineer at Domino Data Lab, where she helps pharmaceutical and biotech organizations accelerate R&D and modernize clinical operations. With a background in biomedical research, software systems, and technical pre-sales in life sciences, Agnes combines deep technical expertise with an understanding of how teams work in highly regulated environments. She specializes in architecting end-to-end technical solutions that solve complex challenges— ranging from initial drug discovery in R&D to regulated clinical pipelines in statistical computing environments (SCE). Agnes partners closely with customers, sales, and product teams to translate complex scientific challenges into practical solutions, helping life sciences organizations scale their data science capabilities.